Statements (35)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
macrolide lactone |
| gptkbp:ATCCode |
none
|
| gptkbp:CASNumber |
83314-01-6
|
| gptkbp:clinicalTrialPhase |
Phase II
|
| gptkbp:discoveredBy |
George R. Pettit
|
| gptkbp:discoveredIn |
1968
|
| gptkbp:foundIn |
gptkb:Bugula_neritina
|
| gptkbp:hasBiologicalActivity |
protein kinase C modulator
|
| gptkbp:hasInChIKey |
QJQFZKWWQXJEMV-UKRRQHHUSA-N
|
| gptkbp:hasMolecularFormula |
C47H68O17
|
| gptkbp:hasSMILES |
CC1=C(C(=O)OC2C(C(C(C(C2OC1=O)OC)O)O)O)C
|
| gptkbp:hasUNII |
8I8Y6G6Z8E
|
| https://www.w3.org/2000/01/rdf-schema#label |
Bryostatin-1
|
| gptkbp:is_not_FDA_approved |
true
|
| gptkbp:is_under_investigation |
true
|
| gptkbp:IUPACName |
(1S,3S,5Z,7R,8E,11S,12S,13E,15S,17R,20R,21R,22S,23R,25S,27R,28S,29R)-1,20,21,22,27,28,29-heptahydroxy-5,8,13-trimethyl-11,15,17,23-hexamethylidene-2,4,6,9,10,12,14,16,18,19,24,26,30,31-tetradecaoxacyclotriacont-8-ene-3,7,11,15,17,20,21,22,23,25,27,28,29,30,31-pentadecanone
|
| gptkbp:molecularWeight |
905.03 g/mol
|
| gptkbp:producedBy |
marine bryozoan
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL375324
5280752 4445612 |
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
gptkb:anemia
nausea vomiting fatigue neutropenia thrombocytopenia myalgia |
| gptkbp:uses |
Alzheimer's disease treatment
anticancer agent HIV latency reversal agent |
| gptkbp:bfsParent |
gptkb:Neurothrope
|
| gptkbp:bfsLayer |
6
|